Gemcitabine and vinorelbine: treatment option in recurrent platinum – resistant ovarian cancer. (2018). European Journal of Oncology and Environmental Health, 22(3-4), 131-137. https://mattioli1885journals.com/index.php/EJOEH/article/view/6086